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Abstract 
Bioactive titania (TiO2) microparticles can be used as drug-releasing cement fillers for the chemotherapeutic 
treatment of metastatic bone tumors. Porous anatase-type TiO2 microspheres around 15 µm in diameter were 
obtained through a sol-gel process involving a water-in-oil emulsion with 30:70 SiO2/H2O weight ratio and 
subsequent NaOH solution treatment. The water phase consisted of methanol, titanium tetraisopropoxide, 
diethanolamine, SiO2 nanoparticles, and H2O, while the oil phase consisted of kerosene, Span 80, and Span 60. 
The resulting microspheres had a high specific surface area of 111.7 m
2
·g
−1
. Apatite with a network-like surface 
structure formed on the surface of the microspheres within 8 days in simulated body fluid. The good 
apatite-forming ability of the microspheres is attributed to their porous structure and the negative zeta potential 
of TiO2. The release of rhodamine B, a model for a hydrophilic drug, was rapid for the first 6 h of soaking, but 
diffusion-controlled thereafter. The burst release in the first 6 h is problematic for clinical applications; 
nonetheless, the present results highlight the potential of porous TiO2 microspheres as drug-releasing cement 
fillers able to form apatite. 
© 2015. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
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1 Introduction 
Lung cancer, breast cancer and prostate cancer often metastasize to bone [1]. Metastatic bone tumors are not 
fatal, but often cause skeletal pain and pathological fractures resulting in a marked decrease in patients’ quality 
of life. Metastatic bone tumors are usually treated with a combination of surgical operations and chemotherapy. 
Firstly, the cancer-affected region is extirpated by surgery and the excision site is sometimes filled with 
injectable calcium phosphate cement in order to achieve early postoperative ambulation [2–4]. After the surgical 
operation, chemotherapy is performed in order to prevent cancer recurrence and metastasis. However, 
chemotherapy often carries a risk of side effects because the drugs are often administered systemically. 
Polymethylmethacrylate (PMMA) and calcium phosphate cements are useful fillers for the excision site 
because of their excellent mechanical properties. PMMA cement is usually encapsulated by fibrous tissues and 
cannot bond to living bone, i.e. show bioactivity, if the matrix does no contain titania (TiO2) nano- or 
microparticles [5, 6] whose apatite-forming ability is responsible for the bioactivity of the cement. TiO2 particles 
able to release drugs would therefore confer both bioactivity and chemotherapeutic abilities to PMMA cement. 
Previously, Yamashita et al. reported that porous TiO2 microspheres approximately 5 µm in diameter can be 
obtained using a sol-gel method with a water-in-oil (W/O) emulsion [7, 8]. In this sol-gel approach, colloidal 
silica (SiO2) nanoparticles are firstly incorporated into TiO2 microspheres and then leached out with a sodium 
hydroxide (NaOH) aqueous solution leaving behind a porous structure. We recently investigated the effects of 
SiO2 nanoparticle size (15, 50, or 200 nm) on the apatite-forming ability of porous TiO2 microspheres in 
simulated body fluid (SBF), and found that pore size and pore shape are important factors influencing the 
formation of apatite [9]. However, the effects of the SiO2 nanoparticle content on the formation of apatite on the 
porous TiO2 microspheres in SBF and the drug-releasing ability of the porous TiO2 microspheres were not 
investigated. In this study, in order to evaluate the potential of porous TiO2 microspheres as apatite-forming, 
drug-releasing cement fillers, we investigated first, the apatite-forming ability of porous TiO2 microspheres 
prepared with different SiO2 nanoparticle contents, and second, the drug-releasing behavior of the porous TiO2 
microspheres by using rhodamine B as a model for a hydrophilic drug [10, 11]. 
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2 Experimental procedures 
2.1 Sample preparation 
All of the reagent-grade chemicals were purchased from Wako Pure Chemical Industries, Tokyo, Japan. Porous 
TiO2 microspheres were prepared using a sol-gel method in W/O emulsion, based on our previous study [9]. For 
the oil phase, kerosene (54.0 g), Span80 (9.0 g), and Span60 (3.0 g) were mixed at 40 °C for 15 min in a 
homogenizer (HG-200, AS ONE Corp., Osaka, Japan) at 1800 rpm. For the water phase, methanol (2.7 g), 
titanium tetraisopropoxide (3.36 g), and diethanolamine (2.0 g) were mixed at 0 °C with a magnetic stirrer 
(HS-360, AS ONE Corp., Osaka, Japan). 
Separately, SiO2 nanoparticle suspensions with varying SiO2 contents were prepared by adding different 
amounts of colloidal SiO2 (Snowtex
®
 XL, Nissan Chemical Industries, Ltd., Tokyo, Japan) to ultrapure water 
(H2O). The average size and concentration of the SiO2 nanoparticles in the colloid were 50 nm and 40 wt%, 
respectively. The total H2O content of the dispersion was fixed at 4.2 g by changing the amount of H2O added. 
Table 1 gives the sample names, the corresponding SiO2 and H2O contents, and the SiO2/H2O weight ratios in 
the SiO2 nanoparticle dispersions. The number in the sample name (S-xx) indicates its SiO2 content (wt%). The 
SiO2 nanoparticle dispersion was mixed with the water phase and then dropped into the oil phase under 
continuous mixing in the homogenizer to achieve a W/O emulsion. The mixing was prolonged at 40 °C for 20 
min at 1800 rpm, at 50 °C for 20 min at 1800 rpm, at 60 °C for 70 min at 1800 rpm, and finally at 60 °C for 70 
min at 1700 rpm. After mixing, the W/O emulsion was centrifuged at 3000 rpm for 5 min (CN-1050, AS ONE 
Corp., Osaka, Japan) and the supernatant liquid was removed by decantation. The precipitates were twice 
washed with 30 mL of ethanol, dried at 60 °C for 12 h, and then heat-treated at 600 °C for 5 h in an electric 
furnace (FO100, Yamato Scientific Co., Ltd., Tokyo, Japan), with the temperature increased at a rate of 
5 °C·min
−1
. 
To create porous structures, the heat-treated precipitates prepared with 0:100 or 10:90 weight ratios of 
SiO2/H2O were soaked in 4 mL of 3 mol·L
−1
 (M) sodium hydroxide (NaOH) solution, while those with SiO2/H2O 
weight ratios of 20:80 or 30:70 were soaked in 4 mL of 1 M NaOH solution at room temperature for 24 h.  
 
2.2 Characterization of the samples 
The morphology of the samples was observed by scanning electron microscopy (SEM; VE-8800, Keyence Corp., 
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Osaka, Japan). The measurements were performed in standard SEM imaging mode, at an accelerating voltage of 
2 kV and a working distance of 8 mm. The samples were not pre-coated with electrically conductive materials 
prior to observation. The crystalline phases of the samples were investigated by powder X-ray diffraction (XRD; 
MiniFlex600HDA, Rigaku Corp., Tokyo, Japan), with a Cu K source operating at 40 kV-15 mA and with a 
scanning rate of 10 °·min
−1
. The structures of the samples were investigated by Fourier-transformed infrared 
spectroscopy (FT-IR; FT/IR-6200, JASCO Corp., Tokyo, Japan), by recording transmission spectra using the 
potassium bromide (KBr) pellet method. The KBr content of the testing samples was kept at around 0.125 wt%. 
The specific surface area (SSA) of the samples was measured with a gas absorption analyzer (Autosorb
®
-iQ-C, 
Quantachrome Corp., Florida, USA), and the pore size distribution in sample S-30 before and after NaOH 
solution treatment was derived from volumetric adsorption measurements (BELSORP-mini II, BEL Japan, 
Osaka, Japan). The samples were heated at 200 °C for 2 h prior to measurements in order to remove adsorbed 
water. The zeta potentials of the samples were measured by laser electrophoresis spectroscopy (ZS90, Malvern 
Instruments Ltd., Worcestershire, UK) at pH 7.4 in saline. The pH of the saline was adjusted using 10 mM 
aqueous solutions of HCl and NaOH. 
 
2.3 Soaking of the samples in SBF 
The SBF was prepared by dissolving reagent-grade chemicals in ultrapure water according to the 
ISO23317:2012 protocol. All chemicals used for the preparation of SBF were purchased from Nacalai Tesque, 
Inc., Kyoto, Japan. Different amounts of the samples (S-0: 47.3 mg, S-10: 7.5 mg, S-20: 6.4 mg, S-30: 6.1 mg) 
were soaked statically in 50 mL SBF at 36.5 °C for 8 days. The different amounts used for each sample ensured 
matching surface areas. The SBF was refreshed every two days. 
 
2.4 Evaluation of rhodamine B loading and release for sample S-30 
Rhodamine B adsorption and release was evaluated for sample S-30 as outlined in a previous study [10]. A total 
of 2.5 mg of Sample S-30 was soaked in a microtube containing 1 mL of a 0.5 mg·mL
−1
 rhodamine B solution, 
whose concentration was determined by the solubility of rhodamine B in water. The microtube was rotated at 3 
rpm for different periods ranging from 1 to 12 h, with a tube rotator (TR-350, AS ONE Corp., Osaka, Japan). 
After a given period, the sample was removed from the rhodamine B solution by centrifugation at 3000 rpm for 
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5 min (CN-1050, AS ONE Corp., Osaka, Japan) and the rhodamine B concentration in the supernatant was 
measured by spectrophotometry (PD-303S, APEL Co., Ltd., Saitama, Japan). The amount of rhodamine B 
loaded into sample S-30 was calculated from the rhodamine B concentration in the supernatant. 
After washing the sample with 1 mL of ultrapure water at the end of the 12 h experimental period, the 
resulting rhodamine B-loaded S-30 sample was soaked in 1 mL of ultrapure water in a microtube that was then 
rotated with a tube rotator at 3 rpm for different periods ranging from 1 to 96 h. After a given period, the sample 
was extracted by centrifugation, and the amount of rhodamine B in the supernatant was measured by 
spectrophotometry. Six S-30 samples were subjected to these evaluations. 
 
3 Results and discussion 
Fig. 1 shows SEM images of the different samples. Microspheres around 8 µm in diameter with smooth surfaces 
are observed for sample S-0 while marginally larger ones, approximately 10 µm in diameter with slightly rough 
surfaces are observed for samples S-10 and S-20. For sample S-30, the microspheres are around 15 µm in 
diameter with slightly rough surfaces. These results indicate that the incorporation of SiO2 nanoparticles during 
preparation increases the size of the resultant microspheres, possibly due to the increased viscosity of the sol 
solution. The rough surfaces of samples S-10, S-20, and S-30 are formed by the dissolution of SiO2 nanoparticles 
in the NaOH solution. 
Figs. 2a and 2b respectively show XRD patterns obtained from samples before and after NaOH solution 
treatment, in which strong diffraction peaks ascribed to anatase (PDF: 21-1272) are observed for all samples. In 
addition, small diffraction peaks associated with rutile (PDF: 21-1276) are visible in the spectrum for sample S-0, 
while for samples S-10, S-20 and S-30, a broad peak ascribed to amorphous colloidal SiO2 [13] is observed 
around 2 = 22° before NaOH treatment (Fig. 2a) and also after (Fig 2b) for the latter two samples. This suggests 
that for samples S-20 and S-30, some of the additive SiO2 nanoparticles still remain even after soaking in a 1 M 
NaOH solution. Higher concentrations of NaOH are expected to better dissolve the SiO2 nanoparticles, but 
soaking samples S-20 and S-30 in 1.5 M or 3 M NaOH solution resulted in the fracture of some of the 
microspheres (data not shown). One speculates that at higher NaOH concentrations, aggregates of SiO2 
nanoparticles are dissolved in the microspheres resulting in their fracture. It is noteworthy that the anatase 
diffraction peaks obtained for samples S-20 and S-30 are broader and less intense than those recorded for 
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samples S-0 and S-10, and that rutile is not formed in samples S-10, S-20, or S-30. These results indicate that the 
anatase phase precipitated in samples S-20 and S-30 is less crystalline than in S-0 and S-10 and that the 
incorporation of SiO2 nanoparticles inhibits the phase transition from anatase to rutile. This phase transition 
occurs via direct formation on the surface of TiO2 particles and/or via the nucleation of rutile points in direct 
contact with anatase particles [14]. Here, the SiO2 nanoparticles might stabilize the surface of the TiO2 particles 
to suppress the direct formation thereon of rutile and/or might prevent anatase particles coming into direct 
contact [14, 15]. 
Figs. 3a and 3b respectively show FT-IR spectra obtained from the samples before and after NaOH solution 
treatment. Absorption bands ascribed to Si-O-Si are observed at around 1100, 1020, 800, and 480 cm
−1
 for 
samples S-10, S-20, and S-30 before NaOH solution treatment [16], that remain visible in Fig. 3b for the latter 
two samples. These results indicate, in agreement with those derived from Fig. 2, that the SiO2 nanoparticles 
added to sample S-10 are completely dissolved by the NaOH treatment, but a small proportion of these remain in 
samples S-20 and S-30 even after treatment. Furthermore, weaker absorption bands ascribed to Si-OH are 
observed at around 950 cm
−1
 for samples S-20 and S-30 [16], suggesting that in these samples, Si-OH groups 
form on the surface of the remaining SiO2 nanoparticles. 
Fig. 4 shows distributions of pore sizes in sample S-30 before and after NaOH solution treatment, and reveals 
that the NaOH solution treatment leads to a general increase in the pore size, probably due to the dissolution of 
SiO2 nanoparticles. Note that the effect of the SiO2 nanoparticle content on pore size distributions will be the 
subject of a future study.  
Table 2 lists the SSA and zeta potential obtained for each sample. Samples S-10, S-20, and S-30 have 
remarkably higher SSAs than sample S-0, which suggests that a porous structure was successfully formed in the 
former samples. The SSA increases with the SiO2 nanoparticle content as expected, but the difference in SSA 
between samples S-20 and S-30 is relatively small. This might be because the SiO2 nanoparticles were not 
completely dissolved by soaking in the NaOH solution for these samples, as mentioned above regarding the 
experimental results in Figs. 2 and 3. The (negative) zeta potentials measured for these samples range from 
−31.2 to −26.2 mV, with those for samples S-20 and S-30 being lower than that of sample S-10 because of the 
presence of residual SiO2, which has a lower zeta potential than TiO2 [17]. 
Fig. 5 shows SEM images of the samples obtained after soaking in SBF. Precipitates with a network-like 
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surface structure are observed, in greater number for sample S-30 than for the others. Fig. 6 shows the XRD 
patterns recorded for the same samples. The hydroxyapatite (PDF #1-071-5048) peaks observed in all of the 
diffraction patterns are most intense for sample S-30, in good agreement with the images in Fig. 5. The good 
apatite-forming ability of sample S-30 in SBF is attributed to its porous structure [18] and the negative zeta 
potential of TiO2, which contributes to the electrostatic attraction of Ca
2+
 ions from SBF [19]. Also, the Si-OH 
groups, which, as suggested by the FT-IR results in Fig. 3, form on the residual SiO2 nanoparticles during 
soaking in NaOH solution, may also contribute to apatite formation [20]. Elsewhere, anatase and/or rutile have 
been shown to form during chemical and thermal treatments on titanium and titanium alloys whose 
apatite-forming ability was associated with the magnitude of the positive or negative zeta potentials [19, 21–23]. 
Here however, the apatite-forming ability of sample S-30 is apparently higher than that of sample S-0 despite 
their zeta potentials being almost identical (S-0: −29.9 mV and S-30: −31.2 mV). This suggests that the 
apatite-forming ability of the present samples is affected more by crystallinity or porosity than by the zeta 
potential [9]. Our previous study [9] also suggests that pore size might affect the apatite-forming ability of these 
materials and this will be investigated more extensively in the future.  
The biological response of PMMA cement containing sample S-30 as well as the cytotoxicity of sample S-30 
are interesting in the context of potential clinical applications. It is reasonable to assume that S-30-containing 
PMMA cement can bond to living bone in vivo. Indeed, PMMA cement containing TiO2 nanoparticles (average 
particle size: 200 nm) and TiO2 microparticles (average particle size: 1.55 µm) have been shown to bond to bone 
directly without fibrous capsulation [5, 6]. Besides, artificial materials that form apatite in SBF can also do so in 
vivo and bond to living bone trough the apatite [24]. 
Fig. 7 shows that the amount of rhodamine B loaded into sample S-30 increases up to 10.7 mg·g
−1
 for soaking 
times up to 12 h, but then decreases slightly after 18 h of soaking. This indicates that the maximum loading of 
sample S-30 with rhodamine B is obtained for a soaking time of 12 h. 
Fig. 8 shows the cumulative amount of rhodamine B released from sample S-30. Rhodamine B is released 
rapidly for soaking times up to 6 h but more gradually thereafter. Approximately 63 % of the loaded rhodamine 
B is released from the sample after soaking for 96 h. Sample S-30 is negatively charged in aqueous conditions 
(see Table 2) and since rhodamine B is a cationic dye it may be adsorbed electrostatically on sample S-30. 
Plotting the amount of rhodamine B released as a function of the square root of time reveals a linear correlation 
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for soaking times longer than 6 h, with a high coefficient of determination (R
2
, see Fig. 9). This indicates that the 
release of rhodamine B is diffusion-controlled for soaking times longer than 6 h [25]. The burst release in the 
first 6 h is undesirable for clinical applications and is a problem to be solved in the future. The pore size of the 
microspheres should affect the loading and release of drugs and this can be adjusted by using SiO2 nanoparticles 
with different sizes [9]. However, since only sample S-30 was amenable to pore size measurements, the results 
of the present study are insufficient to discuss this effect, and further investigations are required. Future studies 
should also concentrate on the release profile of PMMA cement containing sample S-30, since sample S-30 may 
be covered with PMMA when it is used as cement filler. It should be noted however that previous studies suggest 
that TiO2 cement fillers remain partially exposed through the PMMA [5, 6], such that it is reasonable to assume 
that the present rhodamine B release tests to indeed reveal the potential of sample S-30 as a drug-releasing 
cement filler. The release profile could furthermore be improved by adjusting the pore size and/or the zeta 
potential of microspheres, but the present results suggest that porous TiO2 microspheres are potentially valuable 
apatite-forming carriers of hydrophilic and cationic drugs. 
 
4 Summary 
Porous TiO2 microspheres were obtained by leaching the SiO2 out of sol-gel-prepared SiO2-containing TiO2 
microspheres into a NaOH solution. Porous anatase-type TiO2 microspheres approximately 15 µm in diameter 
were formed with a 30:70 SiO2/H2O weight ratio. The incorporation of SiO2 nanoparticles inhibits the phase 
transition from anatase to rutile. Apatite formed within 8 days on the surfaces of porous anatase-type TiO2 
microspheres soaked in SBF. The apatite-forming ability of the microspheres is attributed to their porous 
structure and the negative zeta potential of both TiO2 and the Si-OH groups that, these results suggest, form on 
the residual SiO2 nanoparticles. The release of rhodamine B, a model for a hydrophilic drug, was rapid for the 
first 6 h, but diffusion controlled for soaking times longer than 6 h. The burst release in the first 6 h is a problem 
to be solved for clinical applications, but the present results highlight the potential of these porous TiO2 
microspheres as drug-releasing cement fillers with apatite-forming ability.  
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Figure and table captions 
Fig. 1 Scanning electron micrographs obtained from SiO2-containing TiO2 microsphere samples (S-xx, with xx 
indicating the SiO2 content in wt%) after NaOH solution treatment.  
Fig. 2 X-ray diffraction patterns obtained from SiO2-containing TiO2 microsphere samples (S-xx, with xx 
indicating the SiO2 content in wt%) (a) before and (b) after NaOH solution treatment. 
Fig. 3 Fourier transform infrared spectra obtained from SiO2-containing TiO2 microsphere samples (S-xx, with 
xx indicating the SiO2 content in wt%) (a) before and (b) after NaOH solution treatment. 
Fig. 4 The distribution of pore sizes in the TiO2 microsphere sample containing 30 wt% SiO2 before and after 
NaOH solution treatment. 
Fig. 5 Scanning electron micrographs obtained from SiO2-containing TiO2 microsphere samples (S-xx, with xx 
indicating the SiO2 content in wt%) after soaking in simulated body fluid for 8 days. 
Fig. 6 X-ray diffraction patterns obtained from SiO2-containing TiO2 microsphere samples (S-xx, with xx 
indicating the SiO2 content in wt%) after soaking in simulated body fluid for 8 days. 
Fig. 7 Amount of rhodamine B loaded into TiO2 microsphere samples containing 30 wt% SiO2 as a function of 
the soaking time in 1 mL of a 0.5 mg·mL
−1
 rhodamine B solution. 
Fig. 8 Cumulative amount of rhodamine B released from TiO2 microsphere samples containing 30 wt% SiO2 as a 
function of the soaking time in 1 mL of ultrapure water. 
Fig. 9 Cumulative amount of rhodamine B released from TiO2 microsphere samples containing 30 wt% SiO2 as a 
function of the square root of the soaking time in 1 mL of ultrapure water. 
Table 1 Sample names and the corresponding colloidal SiO2 contents, H2O contents and SiO2/H2O ratios in the 
SiO2 nanoparticle suspensions. 
Table 2 The specific surface area and zeta potential measured for SiO2-containing TiO2 microsphere samples 
(S-xx, with xx indicating the SiO2 content in wt%). 
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R2=0.97 
Sample name S-0 S-10 S-20 S-30 
Colloidal SiO2 [g] 0.000 1.167 2.625 4.500 
H2O [g] 4.200 3.500 2.625 1.500 
SiO2/H2O [weight ratio] 0/100 10/90 20/20 30/70 
Table 1  Sample names, amounts of colloidal SiO2 and H2O and 
SiO2/H2O weight ratio in the SiO2 nanoparticle suspension 
Table
Sample S-0 S-10 S-20 S-30 
SSA [m2·g−1] 14.5 91.2 107.0 111.7 
Zeta potential [mV] -29.9 -26.2 -27.3 -31.2 
Table 2  SSAs and zeta potentials of samples. 
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